April 1, 2019
Negin Fadaee, AA; Laura Mazer, MD; Rajeev Sharma, MD; Isabel Capati, RN, BSN; Bonnie Balzer, MD, PhD; and Shirin Towfigh, MD, FACS, report in the May 2019 issue of the Journal of the American College of Surgeons (JACS) that there is no clinical value in submitting mesh specimens for microscopic surgical pathology evaluation, regardless of clinical indication for mesh removal, and they determined that no clinical claims can be made based on pathology findings from explanted mesh. Meanwhile, microscopic evaluation does incur additional cost to the consumer. The authors recommend explanted mesh be submitted for gross examination only for documentation purposes in the medical records.
This article and all other JACS content is available at journalacs.org.